Category: us corporate news

us corporate news

Supernus Pharmaceuticals 2025 Annual Report: CNS Drug Portfolio, Pipeline, IP, and Market Overview

Minichart

March 3, 2026

Supernus Pharmaceuticals, Inc. 2025 Annual Report: Key Highl...

Continue Reading 0

us corporate news

JAKKS Pacific, Inc. 2025 Annual Report: Business Overview, Growth Strategy, Risk Factors, and Financial Results

Minichart

March 3, 2026

JAKKS Pacific, Inc. 2025 Annual Report: Key Highlights and S...

Continue Reading 0

us corporate news

Rocket Companies, Inc. 2025 Annual Report (10-K): Financials, Business Overview, Risks & SEC Filings

Minichart

March 3, 2026

Rocket Companies, Inc. 2025 Annual Report: Key Highlights fo...

Continue Reading 0

us corporate news

Apartment Investment & Management Company (AIV) 2025 Annual 10-K Report: Company Overview, Financials, and SEC Filings

Minichart

March 3, 2026

Apartment Investment & Management Company (AIV) 2025 Annual ...

Continue Reading 0

us corporate news

Limbach Holdings, Inc. 2025 Annual Report: Business Overview, Financial Highlights, Risk Factors, and Segment Analysis

Minichart

March 3, 2026

Limbach Holdings, Inc. 2025 Annual Report - Key Investor Ana...

Continue Reading 0

us corporate news

CBIZ, Inc. (CBZ) 2025 SEC Filing: XBRL Cover Data, Company Info, and Compliance Details

Minichart

March 3, 2026

CBIZ, Inc. Files Form 10-K/A Amendment: Correction to Shares...

Continue Reading 0

us corporate news

Nuvation Bio Inc. 2025 Annual Report – Business Overview, Pipeline, Risks, and Commercialization Strategy

Minichart

March 3, 2026

Nuvation Bio 2025 Annual Report: Key Highlights for Investor...

Continue Reading 0

us corporate news

Marathon Digital Holdings 2025 Annual Report: Bitcoin Mining, AI & HPC Expansion, Strategic Investments, and Risk Factors

Minichart

March 3, 2026

MARA Holdings, Inc. 2025 Annual Report Analysis: Key Investo...

Continue Reading 0

us corporate news

Core Scientific, Inc. 2025 Annual Report: High-Density Colocation, Digital Asset Mining, and Business Risks Overview

Minichart

March 3, 2026

Core Scientific 2025 10-K: Detailed Investor Report Core...

Continue Reading 0

us corporate news

Enzon Pharmaceuticals 2025 Annual Report: Financials, Risk Factors, and SEC Filings Overview

Minichart

March 3, 2026

Enzon Pharmaceuticals, Inc. 2025 Annual Report: Key Highligh...

Continue Reading 0

Category: us corporate news

Join Our Investing Seminar